Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. financial statements

Eagle Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2022

RevenueUSD 316.61MEODHD
Net incomeUSD 35.64MEODHD
Cash and equivalentsUSD 55.32MEODHD
Total debtUSD 67.79MEODHD

Eagle Pharmaceuticals, Inc. financials on 6ix · Eagle Pharmaceuticals, Inc. on 6ix